纯氨酸核化物作为Butyrylcholinesterase的选择性抑制剂 - - 一项多学科研究
Vasco Cachatra1, Alice Martins1,2, Maria Conceição Oliveira3
1Centro de Química Estrutural, Institute for Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal. aprauter@ciencias.ulisboa.pt.
研究人员优化了一种选择性butirycholinesterase抑制剂,发现6位和lyxopyranosyl组的修改产生了最强大的化合物. 改进的合成条件提高了这些活性核糖类相似物的产量和区域选择性.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲醇化酶 (BuChE) 选择性抑制剂对于治疗各种神经系统疾病至关重要.
- 之前的研究已经确定了纳米分子抑制的关键结构特征,包括位于2位的基组和纯乙胺基组.
研究的目的:
- 合成具有增强活性和生物可用性的新型纯素核酸类型.
- 通过有针对性的修改来研究BuChE抑制剂的结构活性关系 (SAR).
- 优化合成路径以提高活性化合物的产量和区域选择性.
主要方法:
- 计算研究以了解抑制剂-酶相互作用.
- 合成放射性标记的类似物,以评估体内生物可用性.
- 在不同位置 (4,3,4和6) 脱氧核类型.
- 对合成化合物的胆酶抑制和细胞毒性进行评估.
- 优化N-糖化条件 (温度,脱离组,易斯酸).
主要成果:
- 在位置4和3,4的脱氧导致低胆酶抑制.
- 在位置6的脱氧和加入一个lyxopyranosyl组产生了最强大的化合物 (IC50 3.77.8μM).
- 最活跃的化合物共享α-anomeric立体化学和N7-纯素连接,与化合物一致.
- 在25°C的优化N-糖化条件下,提高了产量 (25%) 和N7区域选择性 (52%的N7总产量).
结论:
- α-链接的N7-纯核酸基架对于BuChE抑制活性至关重要.
- 特定的结构修改,特别是在位置6和一个lyxopyranosyl组,显著提高功效.
- 优化合成策略对于有效生产这些有前途的BuChE抑制剂至关重要.
更多相关视频
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
相关概念视频
Cholinesterases: Distribution and Function
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
